CT, MRI and PET-CT in the diagnosis of cervical cancer

Abstract

YANG Dong, ZHANG Hong-Wen, LIU Hui, QI Jie. CT, MRI and PET-CT in the diagnosis of cervical cancer[J]. Journal of International Oncology, 2014, 41(3): 220-223.

［1］ Porras C, Bennett C, Safaeian M, et al. Determinants of seropositivity among HPV16/18 DNA positive young women［J］. BMC Infect Dis, 2010， 10:238243 ［2］曹振东，白慧杰，韩冰，等. 64排螺旋CT对宫颈癌的诊断及分期价值［J］. 河北医药， 2009， 31（16）：20482050. ［3］钱昊初，郭文立，王思亮，等. 宫颈癌Aquilion ONE 320 CT灌注成像表现初探［J］. 中国临床医学影像杂志， 2012， 23(12):853855. ［4］李相生，周纯武，戴景蕊，等. 多层螺旋CT诊断宫颈癌淋巴结转移的价值［J］. 中国医学影像学杂志， 2008, 1（16）:6163. ［5］ Shweel MA, AbdelGawad EA, AbdelGawad EA, et al. Uterine cervical malignancy：diagnostic accuracy of MRI with histopathologic correlation［J］. J Clin Imaging Sci， 2012， 2：42. ［6］ Kraljevi′c Z, Viskovi′c K, Ledinsky M, et al. Primary uterine cervical cancer: correlation of preoperative magnetic resonance imaging and clinical staging (FIGO) with histopathology findings［J］. Coll Antropol， 2013， 37（2）:561568. ［7］ Zand KR, Reinhold C, Abe H, et al. Magnetic resonance imaging of the cervix［J］. Cancer Imaging, 2007, 7:6976. ［8］ Nicolet V, Carignan L, Bourdon F, et al. MR imagingof clinical stage I and IIa cervical carcinoma：A practical staging approach［J］. Radiographics, 2000, 20（6）：15391549. ［9］ Freeman SJ, Aly AM, Kataoka MY, Addley HC, et al. The revised FIGO staging system for uterine malignancies：implications for MR imaging［J］. Radiographics, 2012, 32（6）：18051827. ［10］ Dhoot NM, Kumar V, Shinagare A, et al. Evaluation of carcinoma cervix using magnetic resonance imaging：correlation with clinical FIGO staging and impact on management［J］. Med Imaging Radiat Oncol, 2012, 56（1）：5865. ［11］ Collecttini F, Hamm B. Uterine cervical cancer:preoperative staging with magnetic resonance imaging［J］. Radiologe, 2011, 51(7):589595. ［12］ Tatsumi M， Cohade C， Bristow RE， et al. Imaging Uterine cervical cancer with FDGPET/CT direct comparison with PET［J］. Mol Imaging Biol, 2009, 11(4):229235. ［13］ Chao A, Ho KC, Wang C, et al. Positron emission tomography in evaluating the feasibility of curative intent in cervical cancer patient with limited distant lymph node metastases［J］. Gynecol Oncol， 2008， 110（2）：172178. ［14］ Kima SK, Choia HJ, Parka SY, et al. Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients［J］. Eur J Cancer, 2009， 45（12）:21032109. ［15］ Choi EK, Kim JK, Choi HJ, et al. Nodebynode correlation between MR and PET/CT in patients with uterine cercival cancer:diffusion weighted imaging versus sizebased criteria on T2WI［J］. Eur Radiol, 2009, 19(8):20242032. ［16］ Engin G, Kucucuk S, Olemz H, et al. Corralation of clinical and MRI staging in cervical carcinoma treated with radiation therapy :A singlecenter eaperience［J］. Diagn Interv Radiol, 2011， 17(1):4451. ［17］ Hori M, Kim T, Murakami T, et al. Uterine cervical carcinoma:preoperative staging with 3.0TMR imaging comparison with 1.5TMR imging［J］. Radiology, 2009, 251(1):96104. ［18］ Soussan M, Wartski M, Cherel P, et al. Impact of FDG PETCT imaging on the decision making in the biologic suspicion of ovarian carcinoma recurrence［J］. Gynecol Oncol, 2008, 108(1):160165. ［19］ Chung HH, Jo H, Kang WJ, et al .Clinical impact of PETCT on the management of suspected cervical cancer recurrence［J］. Gynecol Oncol, 2010, 104(3)：529534. ［20］ EvenSapir E, Inbar M. PET in women with high risk for breast or ovarian cancer［J］. Lancet Oncol, 2010, 11（9）:899905.

[1]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291.
[2]	Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei.Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients[J]. Journal of International Oncology, 2024, 51(1): 37-42.
[3]	Zhang Lu, Jiang Hua, Lin Zhou, Ma Chenying, Xu Xiaoting, Wang Lili, Zhou Juying.Analysis of curative effect and prognosis of immune checkpoint inhibitor in the treatment of recurrent and metastatic cervical cancer[J]. Journal of International Oncology, 2023, 50(8): 475-483.
[4]	Lyu Lu, Sun Pengfei.Gut flora and cervical cancer[J]. Journal of International Oncology, 2023, 50(6): 373-376.
[5]	Zeng Liwu, Du Yuqiang, Zhang Peng, Tao Kaixiong.Progress in imaging evaluation of lateral lymph node metastasis in rectal cancer[J]. Journal of International Oncology, 2023, 50(4): 248-251.
[6]	Chen Yu, Xu Hua, Liu Hai, Chen Shixin.Construction of pathological classification prediction model for malignant pulmonary pure ground-glass nodule patients based on CT imaging[J]. Journal of International Oncology, 2023, 50(11): 655-660.
[7]	Ma Xueyan, Lu Lili, Sun Pengfei.Advances in the immune microenvironment in cervical cancer[J]. Journal of International Oncology, 2023, 50(1): 47-50.
[8]	Zhang Lu, Zhou Juying, Ma Chenying, Lin Zhou.Advances in immunotherapy for recurrent and metastatic cervical cancer[J]. Journal of International Oncology, 2022, 49(9): 517-520.
[9]	Song Tongjun, Deng Rui, Fei Lei, Lei Jinhua, Cao Fengjun.Comparison of the efficacy and safety of percutaneous needle biopsy of pulmonary or pleural lesions guided by CT and ultrasound[J]. Journal of International Oncology, 2022, 49(9): 526-531.
[10]	Shi Yingxia, Hu Lijun, Yu Jingping.Application of immune checkpoint inhibitors in the treatment of recurrent or metastatic cervical cancer[J]. Journal of International Oncology, 2022, 49(9): 568-571.
[11]	Peng Chen, Xie Yintong, Zhang Xin, Xie Peng.Research progress of maintenance therapy for cervical cancer[J]. Journal of International Oncology, 2022, 49(7): 430-435.
[12]	Xiong Chan, Yan Ying, Xie Xiaodong, Meng Fanjie, Yu Huiying.Study on the biological characteristics of polyploid cervical cancer HeLa cells induced by radiation[J]. Journal of International Oncology, 2022, 49(5): 263-269.
[13]	Yuan Chenyang, Zhou Juying.Research progress on prognostic factors of cervical cancer[J]. Journal of International Oncology, 2022, 49(5): 307-313.
[14]	Yuan Chenyang, Zhou Juying, Du Xiao, Ji Huan, Zhao Tianyi.Comparison of 2018 and 2009 FIGO staging system of cervical cancer and analysis of prognostic factors[J]. Journal of International Oncology, 2022, 49(3): 151-163.
[15]	Wang Yue, Wu Qiong, Xu Yuan, Gong Wei, Xu Xiaoting.Screening and treatment progression of elderly cervical cancer[J]. Journal of International Oncology, 2022, 49(12): 754-758.

CT, MRI and PET-CT in the diagnosis of cervical cancer

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments